Posted in | News | Chemical Sensor

Major Global Freight Forwarder Acquires Quantum Sniffer QS-B220 Desktop Explosives Trace Detectors

Implant Sciences Corporationa high technology supplier of systems and sensors for homeland security and defense markets, today announced it has sold multiple units of its Quantum Sniffer™ QS-B220 desktop explosives trace detectors to one of the largest freight forwarders in the world.

The units will be shipped to three different international locations and will be used for scanning cargo. The key decision criteria for the customer's selection of the QS-B220 were its approval to the TSA's latest detection standards and the system's non-radioactive source.

"This is our first sale to this leading global freight forwarder. They were initially attracted to the QS-B220 because of its radioactive material-free design, which makes international deployment much simpler for the customer," stated Implant Sciences' Vice President of Sales and Marketing, Dr. Darryl Jones. "The QS-B220 is the only TSA-approved explosives trace detector on the market today that has a non-radioactive ion source. The customer committed to a multiple unit order because of the clear operational advantages they saw in the system."

About the Quantum Sniffer™ QS-B220 Desktop Explosives Trace Detector
The Quantum Sniffer QS-B220 uses Ion Mobility Spectrometry (IMS) to rapidly detect and identify trace amounts of a wide variety of military, commercial, and homemade explosives. With significantly lower maintenance requirements than competing systems, the QS-B220 can be deployed for a much lower total cost of ownership than other approved products. Featuring a radioactive material-free design, push-button maintenance and diagnostics, and a patented inCal™ internal automatic calibration system, the QS-B220 brings new levels of performance and convenience to desktop trace detection users with unsurpassed ease of use.

About Implant Sciences
Implant Sciences is the leader in next generation Explosives Trace Detection (ETD) technology. In January 2013, the Company became only the third ETD manufacturer, and the sole American-owned company, to have product approval from the US Transportation Security Administration. Implant Sciences has developed proprietary technologies used in its commercial explosives and drugs trace detection systems, which ship to a growing number of locations domestically and internationally. Implant Sciences' QS-H150 portable explosives trace detector has received Qualified Anti-Terrorism Technology Designation and, in addition to receiving TSA approval for air cargo screening, the Company's QS-B220 has also received a Developmental Testing & Evaluation (DT&E) Designation by the U.S. Department of Homeland Security under the Support Anti-terrorism by Fostering Effective Technology Act of 2002 (the SAFETY Act). For further details on the Company and its products, please visit the Company's website.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    L3Harris Technologies, Inc.. (2019, February 24). Major Global Freight Forwarder Acquires Quantum Sniffer QS-B220 Desktop Explosives Trace Detectors. AZoSensors. Retrieved on November 22, 2024 from https://www.azosensors.com/news.aspx?newsID=6040.

  • MLA

    L3Harris Technologies, Inc.. "Major Global Freight Forwarder Acquires Quantum Sniffer QS-B220 Desktop Explosives Trace Detectors". AZoSensors. 22 November 2024. <https://www.azosensors.com/news.aspx?newsID=6040>.

  • Chicago

    L3Harris Technologies, Inc.. "Major Global Freight Forwarder Acquires Quantum Sniffer QS-B220 Desktop Explosives Trace Detectors". AZoSensors. https://www.azosensors.com/news.aspx?newsID=6040. (accessed November 22, 2024).

  • Harvard

    L3Harris Technologies, Inc.. 2019. Major Global Freight Forwarder Acquires Quantum Sniffer QS-B220 Desktop Explosives Trace Detectors. AZoSensors, viewed 22 November 2024, https://www.azosensors.com/news.aspx?newsID=6040.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.